← FDA Drug Approvals (Drugs@FDA)

EMPAVELI

NDA · New Drug Application · Sponsor: APELLIS PHARMS · Approved 2021-05-14

Drug application

FDA Application #

NDA215014

Application type

New Drug Application

Brand name

EMPAVELI

Generic name

PEGCETACOPLAN

Active ingredients

PEGCETACOPLAN

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

APELLIS PHARMS

Manufacturer

Apellis Pharmaceuticals, Inc.

First approval

2021-05-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown